http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-94028-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a73cee5001ad08339ae751c10d9abf71
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-092
filingDate 2005-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b38584b89ed859245b17ae1acae91f00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5aa9adb79b91cc60a0082ed1f17b426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42f94dc6676633e7ba0293016537f1e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd002f689528db4d57058ef3f7e84dc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c944b09be4eaec809a446b73c05bcbb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4557b81683f857de8e2377686c896341
publicationDate 2011-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-94028-C2
titleOfInvention AMIDO COMPOUNDS AND THEIR APPLICATION AS MEDICINES
abstract The present invention relates to inhibitors of 11-β-hydroxysteroid dehydrogenase type 1, mineralocorticoid receptor (MR) antagonists, and pharmaceutical compositions thereof. The compounds of this invention can be used to treat various diseases associated with the expression or activity of 11-β-hydroxysteroid dehydrogenase type 1 and / or diseases associated with excess aldosterone.
priorityDate 2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5839

Total number of triples: 19.